Detalles de la búsqueda
1.
Estimating the long-term cost-effectiveness of exenatide in the United States: an adjunctive treatment for type 2 diabetes mellitus.
Value Health
; 11(1): 22-33, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18237357
2.
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials.
Clin Ther
; 29(1): 139-53, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17379054
3.
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.
Curr Med Res Opin
; 24(1): 275-86, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18053320
Resultados
1 -
3
de 3
1
Próxima >
>>